Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. The company is headquartered in Niagara Falls, New York. The firm specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.
How did POSC's recent EPS compare to expectations?
The most recent EPS for Positron Corp is $, expectations of $.
How did Positron Corp POSC's revenue perform in the last quarter?
Positron Corp revenue for the last quarter is $
What is the revenue estimate for Positron Corp?
According to of Wall street analyst, the revenue estimate of Positron Corp range from $ to $
What's the earning quality score for Positron Corp?
Positron Corp has a earning quality score of B+/49.66663. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Positron Corp report earnings?
Positron Corp next earnings report is expected in
What are Positron Corp's expected earnings?
Positron Corp expected earnings is $, according to wall-street analysts.